Aegerion buys Myalept from AZ for $325M

Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) acquired global rights outside of three Asian territories to Myalept metreleptin from

Read the full 160 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE